Manufacturer copay assistance · Yeztugo (J0738) · Gilead
Eligible commercially… · Maximum benefit Up to $8,000 in cost-sharing assistance per calendar year · Covers Yeztugo drug cost plus up to $100 per treatment toward injection administration. Injection-administration assistance is NOT available to residents of MA, MN, or RI.
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
No foundation fund in our catalog currently matches Yeztugo — check the full fund board.
Yes — Gilead Advancing Access Co-pay Savings Program from Gilead. Eligible commercially insured patients could pay as little as $0. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible commercially insured patients could pay as little as $0 Maximum benefit: Up to $8,000 in cost-sharing assistance per calendar year. Covers Yeztugo drug cost plus up to $100 per treatment toward injection administration. Injection-administration assistance is NOT available to residents of MA, MN, or RI.
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.